Showing results (201-210 of 1,786) with videos related to
Sort By:
Pageof 179
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1990
Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective miceJ Sumegi, E Uzvolgyi, G KleinEuropean Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model systemP Trivedi, G Winberg, G KleinISBT Science Series|April 25, 2020
Pathogen-reduction methods: advantages and limitsH G Klein, B J BryantZeitschrift Fur Rheumatologie|November 1, 1980
[A clinical trial of sulindac in osteoarthrosis]F Rainer, A Ulreich, G KleinInternational Journal of Cancer|June 15, 1982
Reactivity with patient antibodies of partially purified gp40 antigen from immune complexes in Burkitt's lymphoma and nasopharyngeal carcinomaY Gazitt, G Klein, D SulitzeanuActa Medica Austriaca|January 1, 1976
[The effect of uricosuric and uricostatic drugs on DNA metabolism]G Klein, A Wottawa, F RainerJournal of Human Evolution|January 11, 2000
Middle and Later Stone Age large mammal and tortoise remains from Die Kelders Cave 1, Western Cape Province, South AfricaR G Klein, K Cruz-UribeInternational Journal of Cancer|August 15, 1975
Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicityG Bataillon, H Pross, G KleinIntervirology|January 1, 1983
The Epstein-Barr virus-determined nuclear antigen: a previously identified 48K component and higher-molecular-weight forms of the antigen are structurally relatedJ Luka, H Jörnvall, G KleinJournal of Virology|January 1, 1982
Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cellsA Wells, N Koide, G KleinPageof 179